ASTCT

The American Society for Transplantation and Cellular Therapy Scientific Journal: @ASTCT_Journal #Tandem27

[ASTCT @ASTCT]

Choosing a conditioning approach means weighing more than intensity alone. How do available RTC approaches compare? What trade-offs should factor into regimen selection? And how can patient- and disease-specific characteristics help guide your decision? Analyze the evidence and strengthen your approach to individualized regimen selection, earning free CE credit along the way: - https://t.co/b7jz6aDW9z

[ASTCT @ASTCT]

Starts tomorrow: Learn from experts, connect with peers and gain practical insights you can apply immediately in your practice. Register today for the ASTCT Clinical Education Conference.
Register https://t.co/X3qpi5p2A0

[ASTCT @ASTCT]

The field's leading minds. The latest developments. Meaningful connections. Register for Tandem Meetings 2027 and be part of the conversations that are driving the future of transplantation and cellular therapy. https://t.co/4aGMR28dIf

[ASTCT @ASTCT]

Whether you're looking to strengthen your knowledge of established toxicity management strategies or learn about emerging challenges, the ASTCT Toxicities Conference offers education designed to support today's cellular therapy professionals. Register today https://t.co/bmdf8tG2q5

[ASTCT @ASTCT]

Join colleagues from across the field for the virtual ASTCT Clinical Education Conference on Oct. 22-23, for practical education, expert-led discussions and valuable networking opportunities that support excellence in patient care. https://t.co/eXNXiBYQ9b

[ASTCT @ASTCT]

During National Pharmacy Week, ASTCT recognizes pharmacists for their expertise, dedication and critical role in advancing transplantation and cellular therapy. Thank you for the impact you make on patients and care teams every day.

[ASTCT @ASTCT]

The strength of ASTCT comes from members like you — professionals who bring fresh perspectives, share their expertise and help move our field forward. Submit interest to serve on an ASTCT Committee or lead a Special Interest Group (SIG) by Nov. 13.
https://t.co/QXF7uHPDOD

[ASTCT @ASTCT]

Gene therapy is transforming what's possible for patients. Join leading clinicians, researchers and innovators at the ASTCT Gene Therapy Summit for timely education, meaningful discussions and insights into the future of care. https://t.co/KUmtLgO5Bd

[ASTCT @ASTCT]

Can TIL therapy become a new treatment option for patients with sarcoma?
In this episode of ASTCT Talks, host Daniel Olson, MD, is joined by John Mullinax, MD, and Lauren Banks, MD, PhD, to discuss the emerging role of tumor-infiltrating lymphocyte (TIL) therapy in sarcoma. The conversation explores early clinical results, patient selection, tumor procurement, and the multidisciplinary collaboration needed to bring this promising cellular therapy approach to patients with solid tumors.
🎧 Listen now: https://t.co/nW83QPPIf2

[ASTCT @ASTCT]

CAR T-cell therapy has already transformed cancer treatment, but what's next?
At the ASTCT Clinical Education Conference, Siddhartha Ganguly, MD, FACP, will examine how CAR T-cell therapy is advancing beyond currently approved indications and what these developments could mean for the future of patient care.
Join colleagues from across the field and gain valuable clinical insights you can bring back to your practice.
🔗 Register today: https://t.co/F7mrftyk81

[ASTCT @ASTCT]

From tumor heterogeneity and manufacturing challenges to patient access and physician education, the path to bringing cellular therapies to solid tumors requires innovation across the entire care continuum.
In this Nucleus Meet the Author spotlight, Roisin E. O'Cearbhaill, MD, discusses the ASTCT-SITC roadmap for accelerating the safe, scalable, and equitable adoption of cellular therapies for patients with solid tumors.
Read more: https://t.co/VaI0WFeClu

[ASTCT @ASTCT]

Stay ahead of emerging challenges in toxicity management. Register for the ASTCT Toxicities Conference to hear from leading experts and gain practical knowledge that can support better patient outcomes. https://t.co/v4k1YdaZ1w

[ASTCT @ASTCT]

In her latest President’s Message, Margy MacMillan, MD, MSc, FRCPC, reflects on the important role every ASTCT member plays in advancing transplantation and cellular therapy. From advocacy efforts on Capitol Hill to guideline development, education, mentorship, and research, she highlights how our collective expertise helps improve patient care and shape the future of the field. Read more: https://t.co/1W0BnVrOck

[ASTCT @ASTCT]

Join colleagues for breakthrough science, expert-led education, meaningful networking and the latest advances in transplantation and cellular therapy at the upcoming Tandem Meetings.
Register by Nov. 20 to secure the lowest rate: https://t.co/zMMFkRN0W9

[ASTCT @ASTCT]

Meet Frederick Locke, MD, chair of ASTCT’s Committee on Cellular Therapy and a leader in the development of CAR T-cell therapy. In this Q&A, Dr. Locke reflects on the experiences that shaped his career, lessons learned as a physician-scientist, the role of ASTCT in advancing the field, and his vision for the future of cellular therapy. Watch the Video: https://t.co/8suXll7Ky0

[ASTCT @ASTCT]

Want to attend the Tandem Meetings 2027? Travel grants are now available to help support attendance and participation. Apply today and take advantage of this opportunity to join the global transplantation and cellular therapy community.
Apply here: https://t.co/t9qR0xWbkv

[ASTCT @ASTCT]

Webinar: Transplanting Older Patients with TP53-Mutated Disease
There's still time to register. Join ASTCT on Oct. 15 for an expert-led webinar exploring transplant considerations and emerging data for older patients with TP53-mutated disease. https://t.co/emGMBl2xuM

[ASTCT @ASTCT]

Older patients with TP53-mutated disease present unique challenges and considerations. Join ASTCT on Oct. 15 for an expert discussion on transplant decision-making, evolving treatment approaches and practical strategies for improving patient outcomes. https://t.co/ZkxoQBYTTh

[ASTCT @ASTCT]

ASTCT's future is shaped by the leaders who step forward today. Nominate yourself or a colleague for the ASTCT Board of Directors and help guide the Society's strategic priorities, advance the field and support the next generation of leaders by Oct. 16. https://t.co/sOHg1vKrdU

[ASTCT @ASTCT]

How close are we to bringing CAR T-cell therapy directly to patients through in vivo approaches?
Explore the latest developments, emerging research and future potential of in vivo CAR T-cell therapy in this ASTCT Learning Center activity. Gain expert insights into one of the field's most exciting areas of innovation and what it could mean for the future of cellular therapy. Thank you to Johnson & Johnson and Legend Biotech for their generous support of this webinar series.
🔗 Learn more: https://t.co/ZHi1s5sfk1